skip to main content

Biological Sciences and Healthcare, part 4

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Product containing organic acid and organic acid derivative (product) > Product containing carboxylic acid and carboxylic acid derivative (product) > Product containing carbamate (product) > Rivastigmine > Rivastigmine only product > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch
... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Enzyme inhibitor (product) > Product containing acetylcholinesterase inhibitor (product) > Reversible anticholinesterase > Rivastigmine > Rivastigmine only product > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch
... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by structure > Product containing organic acid and organic acid derivative (product) > Product containing carboxylic acid and carboxylic acid derivative (product) > Product containing carbamate (product) > Rivastigmine > Rivastigmine in transdermal dosage form > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch
... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorized by disposition (product) > Enzyme inhibitor (product) > Product containing acetylcholinesterase inhibitor (product) > Reversible anticholinesterase > Rivastigmine > Rivastigmine in transdermal dosage form > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch
... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Product manufactured as transdermal dosage form (product) > Rivastigmine in transdermal dosage form > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch
... > Pharmaceutical / biologic product (product) > Medicinal product (product) > Medicinal product categorised by therapeutic role > Antidementia drug > Rivastigmine in transdermal dosage form > Product containing only rivastigmine in transdermal dose form (medicinal product form) > Rivastigmine 396 microgram/hour prolonged-release transdermal patch

Preferred term

Rivastigmine 396 microgram/hour prolonged-release transdermal patch  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

Has basis of strength substance

Has concentration strength denominator unit

Has concentration strength numerator unit

Has manufactured dose form

Has precise active ingredient

Is a

Plays role

In other languages

URI

http://www.irandoc.acir/onto/irandoc/785065002

Download this concept:

RDF/XML TURTLE JSON-LD